beta
THOR
Synthorx, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA.
Market Cap: 2.2 Billion
Primary Exchange: NASDAQ
Website: http://www.synthorx.com
Shares Outstanding: 32.3 Million
Float: 25.3 Million
Dividend: (%)
Beta: 1.214769757051259
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 208 trading days
From: 2019-02-20 To: 2019-12-04
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|